Monica Thakar Selected Research

ruxolitinib

8/2017

Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica Thakar Research Topics

Disease

2	Leukemia 11/2019 - 05/2013
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2017 - 03/2012
2	Fanconi Anemia (Fanconi's Anemia) 02/2017 - 05/2013
1	Neoplasms (Cancer) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	B-Cell Leukemia (Leukemia, B Cell) 11/2019
1	Reticular dysgenesis 12/2017
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 08/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2013
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2013
1	Bone Marrow Failure Disorders 05/2013
1	Lymphopenia (Lymphocytopenia) 03/2012

Drug/Important Bio-Agent (IBA)

1	Hormones (Hormone)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 11/2019
1	ruxolitinibIBA 08/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2012

Therapy/Procedure

4	Cell Transplantation 01/2023 - 03/2012
1	Therapeutics 01/2023
1	Induction Chemotherapy 11/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2019
1	Drug Therapy (Chemotherapy) 12/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2017
1	Transplantation 05/2013